Image

Community-engaged Hypertension Prevention Program in Black Men

Community-engaged Hypertension Prevention Program in Black Men

Non Recruiting
18-85 years
Male
Phase N/A

Powered by AI

Overview

The CLIP program will train Community Health Workers (CHWs) to screen and identify Black men with elevated blood pressure (BP) or stage 1 hypertension (HTN), initiate lifestyle counseling; and link them to primary care and social services.

Description

The study will consist of:

  1. An implementation phase that will use a cluster randomized cluster trial of 20 barbershops among Black men with elevated BP or Stage 1 HTN, to compare the effect of the Barbershop-based Facilitation (BF) strategy (n=10 barbershops; n=210 participants) vs. self-directed control (i.e. receipt of information for implementation of CLIP without the BF strategy; n=10 barbershops; n=210 participants), on BP reduction, HTN prevention, linkage to care, and adoption of CLIP at 12 months
  2. A post-implementation phase that will use Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) to evaluate the effect of the BF strategy versus self-directed control on sustainability of CLIP 6 months after completion of the trial; and cost-effectiveness over a 10-year time horizon.

Eligibility

Inclusion Criteria:

  1. 18 years of age as of date of data extraction
  2. Repeat customer within the last 3 months
  3. Self-identify as Black
  4. Self-identify as male
  5. Have elevated blood pressure (PB) (120-129/<80 millimeters of mercury (mm Hg)) or untreated stage 1 hypertension (HTN) (130-139/80-89 mm Hg) (defined by American Heart Association's 2017 HTN clinical guidelines)

Exclusion Criteria:

  1. Age <18 years
  2. Prescribed antihypertensive medication
  3. Diagnosis of end-stage renal disease (ESRD)
  4. Condition which interferes with outcome measurement (e.g., dialysis)
  5. Serious medical condition which either limits life expectancy or requires active management (e.g., cancer)
  6. Cognitive impairment or other condition preventing participation in the intervention
  7. Upper arm circumference >50 cm (maximum limit of the extra-large BP cuff)
  8. Active alcohol or substance use disorder (i.e., not sober/abstinent for ≥ 30 days)
  9. Pregnant or planning pregnancy in the next 24 months
  10. Currently nursing a child
  11. Current participation in another research study focused on reducing BP
  12. Unwillingness to provide informed consent

Study details
    Hypertension

NCT05447962

NYU Langone Health

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.